JP2012012367A - Hyaluronidase activity inhibitor - Google Patents

Hyaluronidase activity inhibitor Download PDF

Info

Publication number
JP2012012367A
JP2012012367A JP2010152932A JP2010152932A JP2012012367A JP 2012012367 A JP2012012367 A JP 2012012367A JP 2010152932 A JP2010152932 A JP 2010152932A JP 2010152932 A JP2010152932 A JP 2010152932A JP 2012012367 A JP2012012367 A JP 2012012367A
Authority
JP
Japan
Prior art keywords
hyaluronidase activity
activity inhibitor
solution
soybean germ
hyaluronidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010152932A
Other languages
Japanese (ja)
Inventor
Nami Adachi
奈美 足立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Shinyaku Co Ltd
Original Assignee
Toyo Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Shinyaku Co Ltd filed Critical Toyo Shinyaku Co Ltd
Priority to JP2010152932A priority Critical patent/JP2012012367A/en
Publication of JP2012012367A publication Critical patent/JP2012012367A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a new hyaluronidase activity inhibitor having a component different from a conventional hyaluronidase activity inhibitor.SOLUTION: The hyaluronidase activity inhibitor contains a soybean embryo fermented product obtained by fermenting soybean embryo by Aspergillus oryzae. In this case, the soybean embryo fermented product obtained by fermenting soybean embryo by Aspergillus oryzae is a new hyaluronidase activity inhibitor having a component different from the conventional hyaluronidase activity inhibitor. Consequently, by using this hyaluronidase activity inhibitor, even a person who cannot acquire a sufficiently effect because the conventional hyaluronidase activity inhibitor does not fit to him can expect to gain the effect.

Description

本発明は、麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物を含有することを特徴とするヒアルロニダーゼ活性阻害剤およびそのヒアルロニダーゼ活性阻害剤を含有する化粧品に関する。   The present invention relates to a hyaluronidase activity inhibitor characterized by containing a fermented soybean germ obtained by fermenting soybean germ with Aspergillus oryzae and a cosmetic containing the hyaluronidase activity inhibitor.

ヒアルロン酸は、コラーゲンやエラスチンなどと同様に、哺乳動物の結合組織に含まれ、皮膚の保水、潤滑性、および柔軟性などに寄与する成分である。このように、生体内において、ヒアルロン酸は重要な役割を果たすが、炎症や加齢に伴い、ヒアルロン酸分解酵素(ヒアルロニダーゼ)の活性が亢進し、ヒアルロン酸の分解量が増加してしまう。その結果、ヒアルロン酸の合成と分解とのバランスが崩れるため、炎症反応の亢進、あるいは老化による皮膚のシワ、関節痛が引き起こされるなどの問題が生じる。 Hyaluronic acid, like collagen and elastin, is a component that is contained in the connective tissue of mammals and contributes to the water retention, lubricity, and flexibility of the skin. Thus, hyaluronic acid plays an important role in the living body, but with inflammation and aging, the activity of hyaluronic acid-degrading enzyme (hyaluronidase) increases, and the amount of degradation of hyaluronic acid increases. As a result, the balance between synthesis and decomposition of hyaluronic acid is lost, and problems such as an increased inflammatory response, skin wrinkles due to aging, and joint pain are caused.

この問題を解決するため、ヒアルロニダーゼ活性阻害剤となり得る種々の物質が研究されている。ヒアルロニダーゼ活性阻害剤としては、例えば、茶ポリフェノール類(特許文献1)、タラノキ、Myrica nagi、Parmelia perlata、ビンロウジ(特許文献2)、プルーン果実(特許文献3)、ゼラチン分解物、コラーゲン分解物(特許文献4)、ハマスゲ抽出物(特許文献5)、コウスイガヤ、ムラヤ コエニギイ、スファランサス インディクス、カミメボウキ、イボナシツヅラフジ(特許文献6)、セイヨウシロヤナギ、ビワ、ライム、カキ、タマネギ(特許文献7)、ワイルドタイム抽出物、ホップ抽出物(特許文献8)などが知られている。また、これらのヒアルロニダーゼ活性阻害剤を配合した化粧品なども種々販売されている。   In order to solve this problem, various substances that can become hyaluronidase activity inhibitors have been studied. Hyaluronidase activity inhibitors include, for example, tea polyphenols (Patent Document 1), Taranoki, Myrica nagi, Parmelia perlata, betel wax (Patent Document 2), prune fruit (Patent Document 3), gelatin degradation products, collagen degradation products (Patent Documents) Literature 4), extract of Japanese mussel (Patent Literature 5), Koiusigaya, Muraya Koenigii, Sfarans Indicus, Gymebouki, Ibonashitsuraji (Patent Literature 6), White Willow, Biwa, Lime, Oyster, Onion (Patent Literature 7), Wild A thyme extract, a hop extract (Patent Document 8) and the like are known. Various cosmetics containing these hyaluronidase activity inhibitors are also on the market.

特開平6−9391号公報JP-A-6-9391 特開平6−329544号公報JP-A-6-329544 特開平9−2964号公報JP-A-9-2964 特開平10−265401号公報JP-A-10-265401 特開2003−137726号公報JP 2003-137726 A 特許第3541049号公報Japanese Patent No. 3541049 特開2006−104098号公報JP 2006-104098 A 特開2007−230915号公報JP 2007-230915 A

前述のヒアルロニダーゼ活性阻害剤を用いることにより、ヒアルロン酸の分解が抑制されヒアルロン酸の合成と分解とのバランスを保たれると期待できるが、いずれのヒアルロニダーゼ活性阻害剤が適するかについては個人差があり、人によっては従来のヒアルロニダーゼ活性阻害剤を用いても必ずしも十分な効果を得られないという問題点があった。本発明は、この問題点を解決するためになされたものであり、従来のヒアルロニダーゼ活性阻害剤とは成分が異なる、新規のヒアルロニダーゼ活性阻害剤を提供することを課題とする。 By using the aforementioned hyaluronidase activity inhibitor, it can be expected that the degradation of hyaluronic acid is suppressed and the balance between synthesis and degradation of hyaluronic acid is maintained, but there are individual differences in which hyaluronidase activity inhibitor is suitable. However, depending on the person, there is a problem that a sufficient effect cannot always be obtained even if a conventional hyaluronidase activity inhibitor is used. The present invention has been made to solve this problem, and an object of the present invention is to provide a novel hyaluronidase activity inhibitor having components different from those of conventional hyaluronidase activity inhibitors.

請求項1記載のヒアルロニダーゼ活性阻害剤は、麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物を含有することを特徴とする、ヒアルロニダーゼ活性阻害剤に関する。また、請求項2記載の化粧品は、請求項1記載のヒアルロニダーゼ活性阻害剤を含有する。 The hyaluronidase activity inhibitor according to claim 1 relates to a hyaluronidase activity inhibitor characterized by containing a fermented soybean germ obtained by fermenting soybean germ with koji mold. The cosmetic according to claim 2 contains the hyaluronidase activity inhibitor according to claim 1.

本発明のヒアルロニダーゼ活性阻害剤は、麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物を含有する。ここで、麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物は、従来のヒアルロニダーゼ活性阻害剤とは成分が異なる、新規のヒアルロニダーゼ活性阻害剤である。したがって、本発明のヒアルロニダーゼ活性阻害剤を用いることにより、従来のヒアルロニダーゼ活性阻害剤が適さず、十分に効果を得ることができなかった人であっても、効果を得ることが期待できる。なお、本発明の形態に関しては特に限定されるものではなく、そのまま、または種々の成分を加えて、化粧品類、飲食品類または医薬品類として用いることができる。 The hyaluronidase activity inhibitor of the present invention contains a fermented soybean germ product obtained by fermenting soybean germ with koji mold. Here, the fermented soybean germ obtained by fermenting soybean germ with Aspergillus is a novel hyaluronidase activity inhibitor having components different from those of conventional hyaluronidase activity inhibitors. Therefore, by using the hyaluronidase activity inhibitor of the present invention, it is expected that even a person who has not been able to obtain a sufficient effect because a conventional hyaluronidase activity inhibitor is not suitable. In addition, it does not specifically limit regarding the form of this invention, It can use as cosmetics, food / beverage products, or pharmaceuticals as it is or adding various components.

以下、本発明の実施形態について説明する。なお、本発明は、後述の実施形態の記載により限定されるものではなく、特許請求の範囲における記載の範囲内で種々の変更が可能である。   Hereinafter, embodiments of the present invention will be described. In addition, this invention is not limited by description of the below-mentioned embodiment, A various change is possible within the range of description in a claim.

本発明で用いられる麹菌としては、Aspergillus awamori、Aspergillus oryzae、Aspergillus
kawachii、Aspergillus saitoi、Aspergillus glaucusなどが挙げられる。
As the koji mold used in the present invention, Aspergillus awamori, Aspergillus oryzae, Aspergillus
Kawachii, Aspergillus saitoi, Aspergillus glaucus and the like can be mentioned.

本発明で用いられる麹菌としては、特段の制限はなく、得られる発酵物の風味の良さなどから、好ましくはAspergillus awamoriが用いられる。   As the koji mold used in the present invention, there is no particular limitation, and Aspergillus awamori is preferably used because of the flavor of the obtained fermented product.

本発明で用いられる大豆の品種としては、特段の制限はなく、フクユタカ、タチナガハ、ミヤギシロメ、エンレイ、リュウホウ、スズユタカ、タマホマレ、トヨコマチ、おおすず、トヨムスメなどが挙げられる。   The soybean varieties used in the present invention are not particularly limited, and examples thereof include Fukuyutaka, Tachinagaha, Miyagi Shirome, Enrei, Liuhou, Suzuyutaka, Tamahomare, Toyokomachi, Osuzu, Toyosumume and the like.

本発明で用いられる大豆としては、特段の制限はなく、前述の大豆品種を1種単独または2種以上を混合して使用することができる。   The soybean used in the present invention is not particularly limited, and the aforementioned soybean varieties can be used singly or in combination of two or more.

本発明で用いられる大豆胚芽としては、特段の制限はなく、前述の大豆から常法により得られる大豆胚芽が用いられる。   The soybean germ used in the present invention is not particularly limited, and soybean germ obtained from the aforementioned soybean by a conventional method is used.

本発明において大豆胚芽を発酵するにあたっては、特段の制限はなく、洗浄、乾燥、粉砕、蒸煮、加熱、冷却、加水、pH調製、殺菌など、常法の発酵において行われる工程を行うことができる。   In fermenting soybean germ in the present invention, there are no particular limitations, and steps performed in conventional fermentation, such as washing, drying, pulverization, steaming, heating, cooling, water addition, pH adjustment, and sterilization, can be performed. .

本発明の大豆胚芽発酵物の発酵条件としては、好気条件、嫌気条件が選ばれ得る。   As fermentation conditions of the fermented soybean germ of the present invention, aerobic conditions and anaerobic conditions can be selected.

本発明の大豆胚芽発酵物の発酵時間としては、特段の制限はないが、得られる発酵物の風味の良さから24〜72時間、特に36〜60時間発酵に供されることが好ましい。   The fermentation time of the fermented soybean germ product of the present invention is not particularly limited, but is preferably subjected to fermentation for 24 to 72 hours, particularly 36 to 60 hours, because of the good flavor of the obtained fermented product.

本発明で用いられる発酵の方法としては、特段の制限はなく、常法によるものであれば良い。   The fermentation method used in the present invention is not particularly limited, and any fermentation method may be used.

本発明で用いられる大豆胚芽発酵物の製造方法としては、特段の制限はなく、例えば特許第3014145号に開示される製造方法が挙げられる。   There is no restriction | limiting in particular as a manufacturing method of the soybean germ fermented product used by this invention, For example, the manufacturing method disclosed by patent 3014145 is mentioned.

本発明の「ヒアルロニダーゼ活性阻害剤」とは、ヒアルロニダーゼの活性を阻害し、ヒアルロン酸の分解を抑制する成分を示す。この成分としては、例えば、植物発酵物、植物抽出物、動物抽出物、化合物などが挙げられる。   The “hyaluronidase activity inhibitor” of the present invention refers to a component that inhibits the activity of hyaluronidase and suppresses the degradation of hyaluronic acid. As this component, a plant fermented material, a plant extract, an animal extract, a compound, etc. are mentioned, for example.

本発明のヒアルロニダーゼ活性阻害剤は、そのまま、または種々の成分を加えて、化粧品類、飲食品類または医薬品類として用いることができる。   The hyaluronidase activity inhibitor of the present invention can be used as cosmetics, foods and drinks or pharmaceuticals as they are or with various components added.

前述の化粧品類としては、ローション剤、乳剤、ゲル剤、クリーム剤、軟膏剤などの種々の形態に加工して提供することができる。また、化粧品、医薬品、医薬部外品などとして利用することができる。具体的には、化粧水、化粧クリーム、乳液、クリーム、パック、ヘアトニック、ヘアクリーム、シャンプー、ヘアリンス、トリートメント、ボディシャンプー、洗顔剤、石鹸、ファンデーション、育毛剤、水性軟膏、スプレーなどとして利用することができる。   The aforementioned cosmetics can be provided by being processed into various forms such as lotions, emulsions, gels, creams, ointments and the like. Moreover, it can utilize as cosmetics, a pharmaceutical, a quasi-drug, etc. Specifically, it is used as a lotion, cosmetic cream, milky lotion, cream, pack, hair tonic, hair cream, shampoo, hair rinse, treatment, body shampoo, facial cleanser, soap, foundation, hair restorer, aqueous ointment, spray, etc. be able to.

前述の飲食品類としては、本発明のヒアルロニダーゼ活性阻害剤をそのまま、または種々の栄養成分を加えて、食用に適した形態、例えば、粉末状・粒状・顆粒状・液状・ペースト状・クリーム状・タブレット状・カプセル状・カプレット状・ソフトカプセル状・錠剤状・棒状・板状・ブロック状・丸薬状・固形状・ゲル状・ゼリー状・グミ状・ウエハース状・ビスケット状・飴状・チュアブル状・シロップ状・スティック状などに成形して食品素材として提供することができる。また、水、牛乳、豆乳、果汁飲料、乳清飲料、清涼飲料、青汁、ヨーグルトなどに添加して使用してもよい。   As the above-mentioned food and drink products, the hyaluronidase activity inhibitor of the present invention is used as it is, or various nutritional ingredients are added, for example, in a form suitable for food, for example, powder, granule, granule, liquid, paste, cream, Tablet, capsule, caplet, soft capsule, tablet, rod, plate, block, pill, solid, gel, jelly, gummy, wafer, biscuit, bowl, chewable, It can be formed into a syrup or stick and provided as a food material. Further, it may be used by adding to water, milk, soy milk, fruit juice drink, whey drink, soft drink, green juice, yogurt and the like.

前述の医薬品類としては、例えば、粉末状・粒状・顆粒状・液状・タブレット状・カプセル状・カプレット状・ソフトカプセル状・錠剤状・棒状・板状・ブロック状・丸薬状などに成形して医薬品として提供することができる。   Examples of the aforementioned pharmaceutical products include pharmaceutical products that are molded into powder, granular, granular, liquid, tablet, capsule, caplet, soft capsule, tablet, rod, plate, block, pill, etc. Can be offered as.

本発明のヒアルロニダーゼ活性阻害剤に含まれる大豆胚芽発酵物の配合量としては、乾燥重量として0.00001〜50質量%が好ましく、0.001〜20質量%がさらに好ましく、0.01〜10質量がもっとも好ましいが、用いる剤型、使用対象などの様々の条件に応じて、広範囲でその配合量を適宜設定できる。   As a compounding quantity of the soybean germ fermented product contained in the hyaluronidase activity inhibitor of this invention, 0.00001-50 mass% is preferable as dry weight, 0.001-20 mass% is more preferable, 0.01-10 mass However, depending on various conditions such as a dosage form to be used and a target to be used, the blending amount can be appropriately set in a wide range.

本発明のヒアルロニダーゼ活性阻害剤は、大豆胚芽発酵物の他に、次の成分を更に含有してもよい。例えば、松樹皮抽出物、ジャガイモ抽出物、葛花抽出物、チャ抽出物、チャの花抽出物、大豆抽出物、キャベツ粉末、タマネギ粉末、タマネギ発酵物、ゴマ種子抽出物、リグナン類、青汁素材(大麦若葉、甘藷若葉、アシタバ、ヨモギ、ケールなどの緑葉)などを含有しても良い。   The hyaluronidase activity inhibitor of the present invention may further contain the following components in addition to the fermented soybean germ. For example, pine bark extract, potato extract, kuzu flower extract, tea extract, tea flower extract, soybean extract, cabbage powder, onion powder, onion fermented product, sesame seed extract, lignans, green juice Materials (green leaves such as barley young leaves, sweet potato young leaves, Ashitaba, mugwort, kale) may be contained.

以下、本発明の実施例について説明する。なお、本発明は、後述の実施例に限定して解釈されるものではなく、特許請求の範囲における記載の範囲内で種々の変更が可能である。   Examples of the present invention will be described below. It should be noted that the present invention is not construed as being limited to the examples described below, and various modifications can be made within the scope of the claims.

(大豆胚芽発酵物の製造)
後述のように、大豆の胚芽を調製して麹菌により発酵させ、大豆胚芽発酵物を製造した。
(Manufacture of fermented soybean germ)
As described later, soybean germ was prepared and fermented with Aspergillus oryzae to produce a fermented soybean germ.

即ち、大豆胚芽に対し、水および酢酸を添加し、100℃で150分間蒸煮した。その後、大豆胚芽を30℃に保ち3時間放冷を行った。冷却後、麹菌Aspergillus awamoriを播種し、大豆胚芽に対して35℃で48時間製麹を行った。その後70℃で90分乾燥を行い、蒸気殺菌して、大豆胚芽発酵物を得た。 That is, water and acetic acid were added to soybean germ and steamed at 100 ° C. for 150 minutes. Thereafter, the soybean germ was kept at 30 ° C. and allowed to cool for 3 hours. After cooling, Neisseria gonorrhoeae Aspergillus awamori was inoculated, and soybean germ was subjected to koji making at 35 ° C. for 48 hours. Thereafter, drying was performed at 70 ° C. for 90 minutes, and steam sterilization was performed to obtain a fermented soybean germ product.

(実施例1:ヒアルロニダーゼ活性阻害の測定)
ヒアルロニダーゼ活性阻害を測定するため、後述のように試験を行った。すなわち、ヒアルロニダーゼ、基質、活性化剤および大豆胚芽発酵物を含む溶液(被験溶液)と、ヒアルロニダーゼ、基質および活性化剤を含み大豆胚芽発酵物を含まない溶液(対照溶液)とをそれぞれインキュベートし、ヒアルロニダーゼの作用によって分解した基質の量を測定して比較した。
(Example 1: Measurement of hyaluronidase activity inhibition)
To determine the inhibition of hyaluronidase activity, a test was performed as described below. That is, a solution containing hyaluronidase, a substrate, an activator and a soy germ fermented product (test solution) and a solution containing hyaluronidase, a substrate and an activator but no soy germ fermented product (control solution) are respectively incubated. The amount of substrate degraded by the action of hyaluronidase was measured and compared.

(サンプル溶液、酵素溶液、基質溶液および活性化剤溶液の調製)
前述の大豆胚芽発酵物を0.1M酢酸緩衝液(pH3.9)(以下、酢酸緩衝液と略す)に溶解して調製し、サンプル液とした。また、ヒアルロニダーゼ(シグマ社製)を酢酸緩衝液を用いて1.2mg/mLとなるように調製し、酵素溶液とした。また、ヒアルロン酸ナトリウム(和光純薬工業株式会社製)を酢酸緩衝液を用いて0.64mg/mLとなるように調製し、基質溶液とした。さらに、Compound48/80(シグマ社製)を酢酸緩衝液を用いて0.1mg/mLとなるように調製し、活性化剤溶液とした。
(Preparation of sample solution, enzyme solution, substrate solution and activator solution)
The aforementioned fermented soybean germ was dissolved in 0.1 M acetate buffer (pH 3.9) (hereinafter abbreviated as acetate buffer) to prepare a sample solution. In addition, hyaluronidase (manufactured by Sigma) was prepared using an acetate buffer so as to be 1.2 mg / mL, and used as an enzyme solution. Moreover, sodium hyaluronate (made by Wako Pure Chemical Industries, Ltd.) was prepared using an acetic acid buffer so that it might become 0.64 mg / mL, and it was set as the substrate solution. Further, Compound 48/80 (manufactured by Sigma) was prepared to 0.1 mg / mL using an acetic acid buffer solution to obtain an activator solution.

(被験溶液の調製および吸光度測定)
被験溶液の調製は次のように行った。サンプル溶液100μLに酵素溶液50μLを加えて、37℃にて20分間インキュベートした後、活性化剤溶液を100μL添加し、37℃にて20分間インキュベートした。これに基質溶液を250μL添加して、37℃にて40分間インキュベートした。次いで、0.4N水酸化ナトリウム溶液を100μL添加して、氷を用いて0℃に冷却した。さらに、ホウ酸緩衝液(pH9.1)を100μL加え、3分間煮沸した後、氷冷した。氷冷後、エッペンドルフチューブに175μLを分注し、p−DAB試薬750μLを添加して37℃にて20分間インキュベートしたものを被験溶液とし、585nmにおける吸光度を測定した。
(Test solution preparation and absorbance measurement)
The test solution was prepared as follows. After adding 50 μL of the enzyme solution to 100 μL of the sample solution and incubating at 37 ° C. for 20 minutes, 100 μL of the activator solution was added and incubated at 37 ° C. for 20 minutes. To this, 250 μL of the substrate solution was added and incubated at 37 ° C. for 40 minutes. Next, 100 μL of 0.4N sodium hydroxide solution was added and cooled to 0 ° C. using ice. Further, 100 μL of borate buffer (pH 9.1) was added, boiled for 3 minutes, and then ice-cooled. After cooling with ice, 175 μL was dispensed into an Eppendorf tube, 750 μL of p-DAB reagent was added and incubated at 37 ° C. for 20 minutes, and the absorbance at 585 nm was measured.

(被験溶液blankの調製および吸光度測定)
被験溶液blankは、酵素溶液の代わりに酢酸緩衝液50μLを加えた以外は、被験溶液と同様の操作を行い、吸光度を測定した。
(Preparation of test solution blank and measurement of absorbance)
The test solution blank was subjected to the same operation as the test solution except that 50 μL of acetate buffer was added instead of the enzyme solution, and the absorbance was measured.

(対照溶液の調製および吸光度測定)
対照溶液は、サンプル溶液の代わりに酢酸緩衝液100μLを用いた以外は、被験溶液と同様の操作を行い、吸光度を測定した。
(Control solution preparation and absorbance measurement)
The control solution was subjected to the same operation as the test solution except that 100 μL of acetate buffer was used instead of the sample solution, and the absorbance was measured.

(対照溶液blankの調製および吸光度測定)
対照溶液blankは、酵素溶液の代わりに酢酸溶液50μLを加えた以外は、対照溶液と同様の操作を行い、吸光度を測定した。
(Preparation of control solution blank and measurement of absorbance)
The control solution blank was subjected to the same operation as the control solution except that 50 μL of an acetic acid solution was added instead of the enzyme solution, and the absorbance was measured.

(ヒアルロニダーゼ活性の阻害率の算出)
ヒアルロニダーゼ活性阻害の測定は次の式から求められる阻害率で表した。
阻害率(%)=100−[(A−B)/(C−D)]× 100
A:被験溶液の吸光度。
B:被験溶液blankの吸光度。
C:対照溶液の吸光度。
D:対照溶液blankの吸光度。
(Calculation of inhibition rate of hyaluronidase activity)
The measurement of inhibition of hyaluronidase activity was expressed by the inhibition rate obtained from the following formula.
Inhibition rate (%) = 100 − [(A−B) / (C−D)] × 100
A: Absorbance of the test solution.
B: Absorbance of the test solution blank.
C: Absorbance of the control solution.
D: Absorbance of the control solution blank.

ヒアルロニダーゼ活性の阻害率の結果を表1に示す。   The results of the inhibition rate of hyaluronidase activity are shown in Table 1.

Figure 2012012367
Figure 2012012367

表1に示す通り、大豆胚芽発酵物は、ヒアルロニダーゼ活性阻害作用を有することが明らかとなった。よって、麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物は、ヒアルロニダーゼ活性阻害剤として優れた効果を有することが期待できる。 As shown in Table 1, it was revealed that the fermented soybean germ had a hyaluronidase activity inhibitory action. Therefore, the fermented soybean germ obtained by fermenting soybean germ with Aspergillus can be expected to have an excellent effect as a hyaluronidase activity inhibitor.

本発明のヒアルロニダーゼ活性阻害剤は、従来のヒアルロニダーゼ活性阻害剤とは成分が異なる、新規のヒアルロニダーゼ活性阻害剤である。したがって、本発明のヒアルロニダーゼ活性阻害剤を用いることにより、従来のヒアルロニダーゼ活性阻害剤が適さず、十分な効果を得ることができなかった人であっても、効果を得ることが期待できる。本発明のヒアルロニダーゼ活性阻害剤は、化粧品類、飲食品類または医薬品類に利用することができる。   The hyaluronidase activity inhibitor of the present invention is a novel hyaluronidase activity inhibitor whose components are different from those of conventional hyaluronidase activity inhibitors. Therefore, by using the hyaluronidase activity inhibitor of the present invention, it is expected that even a person who cannot obtain a sufficient effect because a conventional hyaluronidase activity inhibitor is not suitable. The hyaluronidase activity inhibitor of the present invention can be used for cosmetics, foods and drinks or pharmaceuticals.

Claims (2)

麹菌により大豆の胚芽を発酵させた大豆胚芽発酵物を含有することを特徴とする、ヒアルロニダーゼ活性阻害剤。   A hyaluronidase activity inhibitor comprising a fermented soybean germ obtained by fermenting soybean germ with koji mold. 請求項1に記載のヒアルロニダーゼ活性阻害剤を含有することを特徴とする、化粧品。   A cosmetic comprising the hyaluronidase activity inhibitor according to claim 1.
JP2010152932A 2010-07-05 2010-07-05 Hyaluronidase activity inhibitor Pending JP2012012367A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010152932A JP2012012367A (en) 2010-07-05 2010-07-05 Hyaluronidase activity inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010152932A JP2012012367A (en) 2010-07-05 2010-07-05 Hyaluronidase activity inhibitor

Publications (1)

Publication Number Publication Date
JP2012012367A true JP2012012367A (en) 2012-01-19

Family

ID=45599229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010152932A Pending JP2012012367A (en) 2010-07-05 2010-07-05 Hyaluronidase activity inhibitor

Country Status (1)

Country Link
JP (1) JP2012012367A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012208451A1 (en) 2011-05-19 2012-11-22 Ngk Spark Plug Co., Ltd. sensor
JP2013126966A (en) * 2011-11-18 2013-06-27 Kracie Home Products Ltd Moisturizer, moisture-retaining cosmetic and colorant
JP2015140325A (en) * 2014-01-30 2015-08-03 福岡県 Collagenase inhibitor, and cosmetic composition and functional food which contain collagenase inhibitor
JP2017071578A (en) * 2015-10-08 2017-04-13 福岡県 Hyaluronidase inhibitor and method that inhibits the activity of hyaluronidase
CN107137628A (en) * 2016-02-26 2017-09-08 佰研生化科技股份有限公司 Hyaluronidase inhibitor and its application from symbiotic fermentation product
TWI629361B (en) * 2016-02-26 2018-07-11 佰研生化科技股份有限公司 Hyaluronidase inhibitor from symbiotic fermented product and application thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012208451A1 (en) 2011-05-19 2012-11-22 Ngk Spark Plug Co., Ltd. sensor
JP2013126966A (en) * 2011-11-18 2013-06-27 Kracie Home Products Ltd Moisturizer, moisture-retaining cosmetic and colorant
JP2015140325A (en) * 2014-01-30 2015-08-03 福岡県 Collagenase inhibitor, and cosmetic composition and functional food which contain collagenase inhibitor
JP2017071578A (en) * 2015-10-08 2017-04-13 福岡県 Hyaluronidase inhibitor and method that inhibits the activity of hyaluronidase
CN107137628A (en) * 2016-02-26 2017-09-08 佰研生化科技股份有限公司 Hyaluronidase inhibitor and its application from symbiotic fermentation product
TWI629361B (en) * 2016-02-26 2018-07-11 佰研生化科技股份有限公司 Hyaluronidase inhibitor from symbiotic fermented product and application thereof
CN107137628B (en) * 2016-02-26 2021-01-05 佰研生化科技股份有限公司 Hyaluronidase inhibitor derived from symbiotic fermentation product and application thereof

Similar Documents

Publication Publication Date Title
JP2019023215A (en) Maillard reaction inhibitor
JP4878771B2 (en) Epidermal keratinocyte proliferating agent and use thereof
CN103874411A (en) Long chain glycolipids useful to avoid perishing or microbial contamination of materials
JP2012012367A (en) Hyaluronidase activity inhibitor
JP2017141201A (en) Glycosylation inhibitor
TW201210633A (en) Agent for promoting hyaluronic acid production
JP2010095529A (en) Composition for improving lipid metabolism
JP4363841B2 (en) Method for improving solubility of polyphenol in water and aqueous solution containing polyphenol
JP2009107965A (en) Ceramide synthesis promoter, and external preparation for skin and food and drink
JP5534654B2 (en) Anti-inflammatory agent
JP6718158B2 (en) Liver function improver
JP2010120946A (en) Antiinflammatory composition
JP5832714B2 (en) Tyrosinase activity inhibitor and melanin production inhibitor
JP6544503B2 (en) Cosmetic composition and functional food containing collagenase inhibitor and collagenase inhibitor
JP2007091630A (en) Food composition and oral skin ameliorating agent
JP5422137B2 (en) Whitening agent, tyrosinase activity inhibitor, melanin production inhibitor, and skin external preparation for whitening
JP2012012366A (en) Collagenase activity inhibitor
JP4542765B2 (en) Enzyme inhibitor
KR20210066212A (en) Composition for preventing skin anti-aging comprising fermented black rice extract and fermented peanut sprout extract
JP7320270B2 (en) Liver function improver
JP2005089385A (en) Lipoxygenase inhibitor
JP7156720B2 (en) glycation inhibitor
JP6115995B2 (en) Non-enzymatic saccharification reaction inhibitor
JP2011231030A (en) Bleaching agent
KR20170099398A (en) Composition for preventing or improving of wrinkle comprising Impatiens textori extract